MEGAN SMITH: Open Payments
NPI 1003469677 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 55 payments from 15 companies in 2025. Trend: 2023 $602 · 2024 $288 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $231 |
| Boston Scientific Corporation | 2 | $79 |
| PFIZER INC. | 4 | $78 |
| Lilly USA, LLC | 4 | $71 |
| Novo Nordisk Inc | 3 | $62 |
| Exact Sciences Corporation | 2 | $45 |
| Eisai Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $37 |
| Dexcom, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: VRAYLAR, REXULTI, The Cologuard Plus Collection Kit, Leqembi, WaveWriter Alpha Prime 16, ELIQUIS, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
